Vesalius and LRM back Complix

The Luxembourg -based Public Research Centre for Health, or CRP Santé, also joined both venture capital firms in the €5m series-A funding round.

Complix focuses on the discovery and development of medicines based on "Alphabodies", which are known to have therapeutic capabilities. The company opened an office in Luxembourg and is working together with CRP Santé to develop its Alphabody therapy product, which is designed to fight against viral diseases.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Alexandra Carrera on +44 20 7004 7527 or alexandra.carrera@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Healthcare
• Early-stage
• Luxembourg
• Belgium